All Stories

  1. Quantitative Preferences for Lung Cancer Treatment from the Patients’ Perspective: A Systematic Review

    Article • The Patient Patient-Centered Outcomes Research, July 2020, Springer Science + Business Media

    MSc. Yasuo YS Sugitani

  2. Postmarketing Benefit-Risk Assessment for Erythropoiesis-Stimulating Agents Using a Health Care Database

    Article • Therapeutic Innovation & Regulatory Science, July 2016, SAGE Publications

    MSc. Yasuo YS Sugitani

  3. Biomarker-based Bayesian randomized phase II clinical trial design to identify a sensitive patient subpopulation

    Article • Statistics in Medicine, May 2014, Wiley

    MSc. Yasuo YS Sugitani